« FDA Unveils First Phase of Transparency Initiative The U.S. Food | Main | FDA Approves New Drug for Rheumatoid Arthritis The U.S. Food »

FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler The


FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the medicine.
FDA News Search
Breaking FDA Recalls
Breaking FDA Approvals
Health Tip
  • It’s a little known fact that an espresso shot benefits your health in a variety of important ways.
Food & Drug Categories
FDA News Archive
Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources
 

©2006 FDA-News.com. All rights reserved.